Navigation Links
New high fiber barley licensed to grow
Date:6/18/2008

"The recent signing of a license agreement between the CSIRO/Australian Capital Ventures Limited joint venture and Austgrains Pty Ltd has paved the way for large scale commercial crops of BARLEYmax unique grain developed by CSIRO using conventional plant breeding techniques," says the Director of the CSIRO Food Futures Flagship, Dr Bruce Lee.

"It contains more than twice the amount of insoluble and soluble fibre found in wheat or oats, as well as resistant starch, which helps promote healthy digestive bacteria," Dr Lee says.

Austgrains' Managing Director, Warren Hannam, says the unique nutritional characteristics of BARLEYmax are a valuable addition to the range of healthy food ingredients available in Australia.

"Austgrains specialises in supplying grain and functional food ingredients to the food manufacturing industry, making BARLEYmax a perfect fit for our company," he says.

Austgrains Pty Ltd is a private company associated with publicly listed Washington H Soul Pattinson and Company Limited and its group of companies, producing and marketing specialty ingredients such as the Nu Soya range of soy products and omega-3 oils.

BARLEYmax Business Manager, CSIRO's Geoff Ball, says clinical testing by CSIRO Human Nutrition has shown that products made with BARLEYmax such as breakfast cereals, muffins and breads have a low Glycaemic Index and strong bowel health attributes.

"Further testing showed BARLEYmax has excellent processing properties and foods made with the new grain have a naturally sweet, slightly nutty taste," Mr Ball says. "With large volumes to be produced soon by Austgrains, healthy foods made with BARLEYmax are likely to be on Australian breakfast tables in the near future."


'/>"/>

Contact: Geoff Ball
Geoff.Ball@csiro.au
61-262-464-911
CSIRO Australia
Source:Eurekalert

Page: 1

Related biology news :

1. New process makes nanofibers in complex shapes and unlimited lengths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... December 1, 2016 The ... Voice), Future Technology (Iris Recognition System), Vehicle Type ... Global Forecast to 2021", published by MarketsandMarkets, the ... in 2016, and is projected to grow to ... of 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/29/2016)... 2016   Neurotechnology , a provider ... technologies, today released FingerCell 3.0, a software ... that run on low-power, low-memory microcontrollers. FingerCell ... than 128KB of memory, enabling it to ... limited on-board resources, such as: mobile phones, ...
(Date:11/22/2016)... , Nov. 22, 2016   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... LiveWire Healthcare and Life Sciences Awards as "Most ... off an unprecedented year of recognition and growth for ... over 15 years. iMedNet ™ ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Soligenix, Inc. (OTCQB: ... company focused on developing and commercializing products to ... medical need, announced today the long-term follow-up data ... (dusquetide), a first-in-class Innate Defense Regulator (IDR), in ... and neck cancer patients undergoing chemoradiation therapy (CRT).  ...
(Date:12/8/2016)... Dec. 8, 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: ... develops and plans to commercialize innovative therapeutics for ... common stock were approved for trading on the ... on the OTCQX, effective today, under the ticker ... OTCQX market, companies must meet high financial standards, ...
(Date:12/8/2016)... , Dec. 8, 2016 Eutilex Co. ... billion KRW (US $18.9M) Series A financing. This financing ... G.N. Tech Venture and SNU Bio Angel. This new ... 30.5 billion KRW (US $27.7M) since its founding in ... to bolster the development and commercialization of its immuno-oncology ...
(Date:12/8/2016)... 8, 2016   Biocept, Inc . (NASDAQ: ... of clinically actionable liquid biopsy tests to improve ... data featuring its Target Selectorâ„¢ Circulating Tumor Cell ... the detection of actionable biomarkers in patients with ... by Sara Cannon Research Institute (SCRI), the research ...
Breaking Biology Technology: